Literature DB >> 23493073

Linking intestinal homeostasis and liver disease.

Bernd Schnabl1.   

Abstract

PURPOSE OF REVIEW: Interactions of the gut microbiome with the host are important in health and disease. Microbial translocation releases bacterial products that play a key role in progression of chronic liver disease by promoting hepatic injury and inflammation. Although this has long been recognized, we are just beginning to understand the circumstances under which the gut becomes leaky and to discover bacterial metabolites that promote liver disease. In this review, we will summarize recent findings from the last 2 years. RECENT
FINDINGS: Chronic liver disease is associated with an altered microbiome with both qualitative (dysbiosis) and quantitative (overgrowth) differences. This can be viewed as a loss of the symbiotic relationship between the microflora and the host. An imbalanced intestinal homeostasis results in a breach of the gut barrier and subsequent microbial translocation. However, the contribution of the intestinal microflora is beyond simple microbial translocation as a pathogenic factor. Bacterial metabolites resulting from an imbalanced homeostasis and dysbiosis play also a crucial role in liver disease.
SUMMARY: A combination between an initiating liver insult and a disturbance of the gut-host symbiosis synergize in progression of liver disease.

Entities:  

Mesh:

Year:  2013        PMID: 23493073      PMCID: PMC4077188          DOI: 10.1097/MOG.0b013e32835ff948

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  29 in total

1.  Colonic microbiome is altered in alcoholism.

Authors:  Ece A Mutlu; Patrick M Gillevet; Huzefa Rangwala; Masoumeh Sikaroodi; Ammar Naqvi; Phillip A Engen; Mary Kwasny; Cynthia K Lau; Ali Keshavarzian
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-01-12       Impact factor: 4.052

2.  Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.

Authors:  Anne Vrieze; Els Van Nood; Frits Holleman; Jarkko Salojärvi; Ruud S Kootte; Joep F W M Bartelsman; Geesje M Dallinga-Thie; Mariette T Ackermans; Mireille J Serlie; Raish Oozeer; Muriel Derrien; Anne Druesne; Johan E T Van Hylckama Vlieg; Vincent W Bloks; Albert K Groen; Hans G H J Heilig; Erwin G Zoetendal; Erik S Stroes; Willem M de Vos; Joost B L Hoekstra; Max Nieuwdorp
Journal:  Gastroenterology       Date:  2012-06-20       Impact factor: 22.682

Review 3.  Infectious complications of acute and chronic liver disease.

Authors:  Bettina Leber; Walter Spindelboeck; Vanessa Stadlbauer
Journal:  Semin Respir Crit Care Med       Date:  2012-03-23       Impact factor: 3.119

4.  Characterization of fecal microbial communities in patients with liver cirrhosis.

Authors:  Yanfei Chen; Fengling Yang; Haifeng Lu; Baohong Wang; Yunbo Chen; Dajiang Lei; Yuezhu Wang; Baoli Zhu; Lanjuan Li
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

5.  Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.

Authors:  Netanya G Sandler; Christopher Koh; Annelys Roque; Jason L Eccleston; Rebecca B Siegel; Mary Demino; David E Kleiner; Steven G Deeks; T Jake Liang; Theo Heller; Daniel C Douek
Journal:  Gastroenterology       Date:  2011-07-02       Impact factor: 22.682

6.  Intestinal inflammation targets cancer-inducing activity of the microbiota.

Authors:  Janelle C Arthur; Ernesto Perez-Chanona; Marcus Mühlbauer; Sarah Tomkovich; Joshua M Uronis; Ting-Jia Fan; Barry J Campbell; Turki Abujamel; Belgin Dogan; Arlin B Rogers; Jonathan M Rhodes; Alain Stintzi; Kenneth W Simpson; Jonathan J Hansen; Temitope O Keku; Anthony A Fodor; Christian Jobin
Journal:  Science       Date:  2012-08-16       Impact factor: 47.728

7.  Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice.

Authors:  Phillipp Hartmann; Michael Haimerl; Magdalena Mazagova; David A Brenner; Bernd Schnabl
Journal:  Gastroenterology       Date:  2012-07-27       Impact factor: 22.682

Review 8.  Interactions between the microbiota and the immune system.

Authors:  Lora V Hooper; Dan R Littman; Andrew J Macpherson
Journal:  Science       Date:  2012-06-06       Impact factor: 47.728

9.  Linking long-term dietary patterns with gut microbial enterotypes.

Authors:  Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis
Journal:  Science       Date:  2011-09-01       Impact factor: 47.728

10.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

View more
  32 in total

Review 1.  Gut microbiota modulate the immune effect against hepatitis B virus infection.

Authors:  D Xu; Y Huang; J Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-14       Impact factor: 3.267

Review 2.  Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE).

Authors:  Daniel J Raiten; Fayrouz A Sakr Ashour; A Catharine Ross; Simin N Meydani; Harry D Dawson; Charles B Stephensen; Bernard J Brabin; Parminder S Suchdev; Ben van Ommen
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

Review 3.  Novel insights in preventing Gram-negative bacterial infection in cirrhotic patients: review on the effects of GM-CSF in maintaining homeostasis of the immune system.

Authors:  Dong Xu; Manzhi Zhao; Yuhu Song; Jianxin Song; Yuancheng Huang; Junshuai Wang
Journal:  Hepatol Int       Date:  2014-11-21       Impact factor: 6.047

Review 4.  Interactions between the intestinal microbiome and liver diseases.

Authors:  Bernd Schnabl; David A Brenner
Journal:  Gastroenterology       Date:  2014-01-15       Impact factor: 22.682

Review 5.  Methods to determine intestinal permeability and bacterial translocation during liver disease.

Authors:  Lirui Wang; Cristina Llorente; Phillipp Hartmann; An-Ming Yang; Peng Chen; Bernd Schnabl
Journal:  J Immunol Methods       Date:  2015-01-13       Impact factor: 2.303

Review 6.  Shared symptoms and putative biological mechanisms in chronic liver disease: implications for biobehavioral research.

Authors:  Victoria Menzies; Nancy Jallo; Patricia Kinser; Jo Lynne W Robins; Kyungeh An; Carolyn Driscoll; Angela Starkweather; Jasmohan S Bajaj; Debra E Lyon
Journal:  Biol Res Nurs       Date:  2014-07-18       Impact factor: 2.522

7.  CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis.

Authors:  Mohamed A Abdelmegeed; Atrayee Banerjee; Sehwan Jang; Seong-Ho Yoo; Jun-Won Yun; Frank J Gonzalez; Ali Keshavarzian; Byoung-Joon Song
Journal:  Free Radic Biol Med       Date:  2013-09-21       Impact factor: 7.376

8.  Predictive Factors for Intestinal Transmural Necrosis in Patients with Acute Mesenteric Ischemia.

Authors:  Sameh Hany Emile
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

Review 9.  Gut epithelial inducible heat-shock proteins and their modulation by diet and the microbiota.

Authors:  Marie-Edith Arnal; Jean-Paul Lallès
Journal:  Nutr Rev       Date:  2016-02-16       Impact factor: 7.110

Review 10.  Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity.

Authors:  Mercedes Márquez; Clotilde Fernández Gutiérrez del Álamo; José Antonio Girón-González
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.